The protein expression of CD24 was verified by both western blot and IHC staining, and the results indicated that CD24 was highly expressed in human HCC tissues especially in tumor cells, and that sorafenib-resistant cells expressed significantly higher levels of CD24 (Fig. 1c, d). The gene discussed is CD24; the disease is hepatocellular carcinoma.